Ether

Ether

SCHEMBL798549

CCCCCc1ccccc1OS(=O)(=O)O.CCOCC.N

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.48
THRB P10828 1/20 0.48
ALOX5 P09917 1/20 0.44
PTGS2 P35354 1/20 0.44
PPARA Q07869 2/20 0.43
LIPG Q9Y5X9 1/20 0.42
PPARG P37231 1/20 0.41
ELANE P08246 2/20 0.38
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
BID P55957 3/20 0.37
MCL1 Q07820 3/20 0.37
BCL2L1 Q07817 2/20 0.37
BAK1 Q16611 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL66379 0.99 THRA (0.50) THRATHRBALOX5PTGS2PPARA
Ether SCHEMBL1928140 0.99 THRA (0.49) THRATHRBALOX5PTGS2PPARA
Ether SCHEMBL2937392 0.97 THRA (0.51) THRATHRBALOX5PTGS2PPARA
Ether SCHEMBL515387 0.97 THRA (0.51) THRATHRBALOX5PTGS2PPARA
Ether SCHEMBL1712535 0.97 THRA (0.51) THRATHRBALOX5PTGS2PPARA
Ammonia Solution, Strong SCHEMBL371312 0.94 THRA (0.52) THRATHRBALOX5PTGS2PPARA
Ammonia Solution, Strong SCHEMBL10961216 0.93 THRA (0.55) THRATHRBALOX5PTGS2PPARA
Ammonia Solution, Strong SCHEMBL9118739 0.93 THRA (0.55) THRATHRBALOX5PTGS2PPARA
SCHEMBL1101443 0.93 THRA (0.54) THRATHRBALOX5PTGS2PPARA
Sulfuric Acid SCHEMBL7624808 0.92 THRA (0.53) THRATHRBALOX5PTGS2PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113453552-A Composition of ifenesin and pyraclostrobin PI工业有限公司 2021-09-28 CN claimed
CN-113453552-A Composition of ifenesin and pyraclostrobin PI工业有限公司 2021-09-28 CN disclosed
US-9888689-B2 Compositions containing a pyripyropene insecticide and an adjuvant BASF SE (DE) 2018-02-13 US disclosed
US-9723834-B2 Composition containing a pyripyropene insecticide and a base BASF SE (DE) 2017-08-08 US disclosed
EP-2615919-B1 COMPOSITION CONTAINING A PYRIPYROPENE INSECTICIDE AND AN ADJUVANT BASF SE (DE) 2015-01-14 EP disclosed
EP-2615910-B1 COMPOSITION CONTAINING A PYRIPYROPENE INSECTICIDE AND A BASE BASF SE (DE) 2014-07-02 EP disclosed
US-20130190360-A1 Compositions Containing a Pyripyropene Insecticide and an Adjuvant BASF SE (DE) 2013-07-25 US disclosed
EP-2615910-A1 COMPOSITION CONTAINING A PYRIPYROPENE INSECTICIDE AND A BASE BASF SE (DE) 2013-07-24 EP disclosed
EP-2615919-A2 COMPOSITION CONTAINING A PYRIPYROPENE INSECTICIDE AND AN ADJUVANT BASF SE (DE) 2013-07-24 EP disclosed
US-20130184153-A1 Composition containing a pyripyropene insecticide and a base BASF SE (DE) 2013-07-18 US disclosed
WO-2012035015-A2 COMPOSITION CONTAINING A PYRIPYROPENE INSECTICIDE AND AN ADJUVANT BASF SE (DE) 2012-03-22 WO disclosed
WO-2012035010-A1 COMPOSITION CONTAINING A PYRIPYROPENE INSECTICIDE AND A BASE BASF SE (DE) 2012-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184153-A1 Composition containing a pyripyropene insecticide and a base DDT, PIR, PNPO THRA 2139/4885THRB 1235/4885ALOX5 691/4885
US-20130190360-A1 Compositions Containing a Pyripyropene Insecticide and an Adjuvant DDT, PIR, ACHE THRA 1925/4885THRB 1790/4885ALOX5 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.